Advanced Oncotherapy PLC AVO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX 1.93
- Day Range
- GBX 1.75–1.75
- 52-Week Range
- GBX 1.75–25.75
- Bid/Ask
- GBX 0.00 / GBX 0.00
- Market Cap
- GBX 1.04 Bil
- Volume/Avg
- 200,000 / 1.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Advanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing to curing critical unmet conditions. The company's only business segment is Proton Therapy.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 174
- Website
- https://www.avoplc.com
Valuation
|
Metric
|
AVO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
AVO
|
|---|---|
Quick Ratio | 0.13 |
Current Ratio | 1.26 |
Interest Coverage | −4.67 |
Quick Ratio
AVO
Profitability
|
Metric
|
AVO
|
|---|---|
Return on Assets (Normalized) | −16.28% |
Return on Equity (Normalized) | −60.65% |
Return on Invested Capital (Normalized) | −15.52% |
Return on Assets
AVO
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Ssmkcwccn | Jtrqbx | $182.7 Bil | |
SYK
| Stryker Corp | Pqfdlzdht | Lzfrq | $124.6 Bil | |
MDT
| Medtronic PLC | Htfnhcldb | Pjkrws | $105.2 Bil | |
BSX
| Boston Scientific Corp | Jmzkktr | Tltrk | $99.1 Bil | |
EW
| Edwards Lifesciences Corp | Dgfklvpst | Wkbwq | $52.0 Bil | |
DXCM
| DexCom Inc | Jhfxdkwgk | Hrbdz | $51.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Nszppjczc | Dtgc | $24.5 Bil | |
ALGN
| Align Technology Inc | Mgglggzhp | Ghhxtc | $22.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Vtwntwbd | Vsyffb | $18.3 Bil | |
PODD
| Insulet Corp | Ylzzskgfs | Vrypfkc | $11.6 Bil |